NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19

Objective: To determine and compare Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) in predicting severity of disease in patients with COVID-19. Study design: Descriptive comparative study. Place and Duration of study: Department of Medicine, CMH Thal from April to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Muhammad Adil, Zahid Farooq Baig, Muhammad Amir, Sohail Saqib Chatha, Aamir Habib, Muhammad Majid
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2020
Materias:
R
Acceso en línea:https://doi.org/10.51253/pafmj.v70i6.5010
https://doaj.org/article/fcc7efe337174fab8d36de392824c7a4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fcc7efe337174fab8d36de392824c7a4
record_format dspace
spelling oai:doaj.org-article:fcc7efe337174fab8d36de392824c7a42021-12-02T17:16:23ZNEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19https://doi.org/10.51253/pafmj.v70i6.50100030-96482411-8842https://doaj.org/article/fcc7efe337174fab8d36de392824c7a42020-12-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/5010https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To determine and compare Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) in predicting severity of disease in patients with COVID-19. Study design: Descriptive comparative study. Place and Duration of study: Department of Medicine, CMH Thal from April to July, 2020 Patients & Methods: 61 patients of COVID-19 confirmed through polymerase chain reaction were recruited and divided into severe and non severe disease. Complete blood counts were done. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio were calculated and analyzed. Results: 14 patients (23%) of severe disease had mean age of 49.93±19.42 and 47 patients (77%) with non-severe disease had mean age of 33.32±9.16. The mean Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte ratio in patients who had severe disease was 7.20±4.20 and 204.25±148.42 (p=0.001 and p=0.026) respectively. The diagnostic performance of both Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio produced statistically significant area under the curve (AUC), (p <0.001). The adjusted and unadjusted area under curve for Neutrophil to Lymphocyte Ratio was 0.92 (95% CI: 0.85–1.00) and 0.923 (95% CI: 0.839-1.000) and for Platelet to Lymphocyte Ratio it was 0.883 (95% CI: 0.781–0.985) and 0.825(95% CI: 0.707-0.943) respectively. Conclusion: Elevated Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are independent biomarkers which predict severity of disease in COVID-19 patients with Neutrophil to Lymphocyte Ratio being better predictor in terms of diagnostic accuracy. Muhammad AdilZahid Farooq BaigMuhammad AmirSohail Saqib ChathaAamir HabibMuhammad MajidArmy Medical College Rawalpindiarticlecorona virus disease 2019 (covid‐19)neutrophil to lymphocyte ratioplatelet to lymphocyte ratioMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 6, Pp 1609-1615 (2020)
institution DOAJ
collection DOAJ
language EN
topic corona virus disease 2019 (covid‐19)
neutrophil to lymphocyte ratio
platelet to lymphocyte ratio
Medicine
R
Medicine (General)
R5-920
spellingShingle corona virus disease 2019 (covid‐19)
neutrophil to lymphocyte ratio
platelet to lymphocyte ratio
Medicine
R
Medicine (General)
R5-920
Muhammad Adil
Zahid Farooq Baig
Muhammad Amir
Sohail Saqib Chatha
Aamir Habib
Muhammad Majid
NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19
description Objective: To determine and compare Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) in predicting severity of disease in patients with COVID-19. Study design: Descriptive comparative study. Place and Duration of study: Department of Medicine, CMH Thal from April to July, 2020 Patients & Methods: 61 patients of COVID-19 confirmed through polymerase chain reaction were recruited and divided into severe and non severe disease. Complete blood counts were done. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio were calculated and analyzed. Results: 14 patients (23%) of severe disease had mean age of 49.93±19.42 and 47 patients (77%) with non-severe disease had mean age of 33.32±9.16. The mean Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte ratio in patients who had severe disease was 7.20±4.20 and 204.25±148.42 (p=0.001 and p=0.026) respectively. The diagnostic performance of both Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio produced statistically significant area under the curve (AUC), (p <0.001). The adjusted and unadjusted area under curve for Neutrophil to Lymphocyte Ratio was 0.92 (95% CI: 0.85–1.00) and 0.923 (95% CI: 0.839-1.000) and for Platelet to Lymphocyte Ratio it was 0.883 (95% CI: 0.781–0.985) and 0.825(95% CI: 0.707-0.943) respectively. Conclusion: Elevated Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are independent biomarkers which predict severity of disease in COVID-19 patients with Neutrophil to Lymphocyte Ratio being better predictor in terms of diagnostic accuracy.
format article
author Muhammad Adil
Zahid Farooq Baig
Muhammad Amir
Sohail Saqib Chatha
Aamir Habib
Muhammad Majid
author_facet Muhammad Adil
Zahid Farooq Baig
Muhammad Amir
Sohail Saqib Chatha
Aamir Habib
Muhammad Majid
author_sort Muhammad Adil
title NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19
title_short NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19
title_full NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19
title_fullStr NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19
title_full_unstemmed NEUTROPHIL TO LYMPHOCYTE RATIO VS PLATELETS TO LYMPHOCYTE RATIO: BIOMARKERS TO PREDICT SEVERITY OF DISEASE AND THEIR COMPARISON IN PATIENTS OF COVID-19
title_sort neutrophil to lymphocyte ratio vs platelets to lymphocyte ratio: biomarkers to predict severity of disease and their comparison in patients of covid-19
publisher Army Medical College Rawalpindi
publishDate 2020
url https://doi.org/10.51253/pafmj.v70i6.5010
https://doaj.org/article/fcc7efe337174fab8d36de392824c7a4
work_keys_str_mv AT muhammadadil neutrophiltolymphocyteratiovsplateletstolymphocyteratiobiomarkerstopredictseverityofdiseaseandtheircomparisoninpatientsofcovid19
AT zahidfarooqbaig neutrophiltolymphocyteratiovsplateletstolymphocyteratiobiomarkerstopredictseverityofdiseaseandtheircomparisoninpatientsofcovid19
AT muhammadamir neutrophiltolymphocyteratiovsplateletstolymphocyteratiobiomarkerstopredictseverityofdiseaseandtheircomparisoninpatientsofcovid19
AT sohailsaqibchatha neutrophiltolymphocyteratiovsplateletstolymphocyteratiobiomarkerstopredictseverityofdiseaseandtheircomparisoninpatientsofcovid19
AT aamirhabib neutrophiltolymphocyteratiovsplateletstolymphocyteratiobiomarkerstopredictseverityofdiseaseandtheircomparisoninpatientsofcovid19
AT muhammadmajid neutrophiltolymphocyteratiovsplateletstolymphocyteratiobiomarkerstopredictseverityofdiseaseandtheircomparisoninpatientsofcovid19
_version_ 1718381179228389376